This inventor holds 2 USPTO granted patents. Top assignees: Mcdonnell Douglas Corporation, Washington University. Active years: 1989-1994.
Company Filing History:
2 out of 1,173 
2 out of 1,379 
Years Active: 1989-1994
Title: Edward H Finke: Innovator in Islet Isolation Processes
Introduction
Edward H Finke is a notable inventor based in Jennings, MO (US). He has made significant contributions to the field of medical technology, particularly in the area of islet isolation processes. With a total of 2 patents, Finke's work has had a lasting impact on diabetes research and treatment.
Latest Patents
Finke's latest patents focus on a method of producing intact islets of Langerhans in an insulin-producing condition. This innovative process utilizes a mixture of Hank's solution and 10% by volume fetal calf serum to ductally distend the human pancreas. The exocrine tissue of the pancreas is then digested at approximately 37 degrees Celsius using an enzyme preparation that includes collagenase, trypsin, and proteolytic enzymes at a concentration of about 0.2% by weight. The digestion process is carefully monitored at regular intervals. After digestion, the pancreas is comminuted, filtered, and intact islets of Langerhans are recovered, retaining their insulin-producing properties.
Career Highlights
Throughout his career, Edward H Finke has worked with prominent organizations such as McDonnell Douglas Corporation and Washington University. His experience in these institutions has contributed to his expertise in the field of medical technology and innovation.
Collaborations
Finke has collaborated with notable individuals in his field, including David W Scharp and Paul E Lacy. These collaborations have further enhanced his research and development efforts in islet isolation processes.
Conclusion
Edward H Finke's contributions to the field of islet isolation processes demonstrate his commitment to advancing medical technology. His innovative methods have the potential to improve diabetes treatment and patient outcomes.